Jun 22, 2015 at 10:57 | Source: Moneycontrol.com
"The company had signed settlement agreement with few bond holders for settlement of the then outstanding 36,789 bonds of USD 1,000 each in principal value. Out of that 21,511 bonds have already been settled and cancelled," said the drug maker in its filing.
Jun 20, 2015 at 13:48 | Source: PTI
FMCG firm RB said it will do a thorough investigation and collaborate with authorities after the UP Food and Drug Administration alleged a lesser weight in its Dettol soap.
Jun 19, 2015 at 13:36 | Source: PTI
On April 1, the drug firm had said that it would acquire select portfolio of established brands of UCB in India, Nepal, Sri Lanka and Maldives for Rs 800 crore.
Jun 19, 2015 at 13:10 | Source: Moneycontrol.com
"US Court of Appeals for Federal Circuit has again found Teva's US 808 patent for Copaxone to be invalid as indefinite. The company awaits approval from the US Food and Drug Administration (US FDA) to launch the product," said Natco in its filing to the exchange.
Jun 18, 2015 at 11:00 | Source: CNBC-TV18
The most prominent name in the mass exodus is that of its CFO Rajesh Garg, who quit to pursue his entrepreneurial ambitions. Company CEO Subhanu Saxena is overseeing finance functions in the interim.
Jun 18, 2015 at 10:12 | Source: Moneycontrol.com
"Orchid has received approval from the USFDA for the abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets (320 mg) with 180 days of generic drug exclusivity," said the drug maker in its filing.
Jun 17, 2015 at 21:42 | Source: PTI
A day after the UP Food and Drug Administration said it had found detergent in one of the milk samples of Mother Dairy, the co-operative said the tested was done on "loose milk samples collected at village level" which were yet to be accepted by it.
Jun 17, 2015 at 18:50 | Source: PTI
The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Gemifloxacin Mesylate tablets in the strength of 320 mg, Orchid Chemicals & Pharmaceuticals said in a filing to BSE.
Jun 17, 2015 at 18:14 | Source: Reuters
More than a decade after it made headlines globally for offering to make AIDS drugs for under USD 1 a day, Cipla gets nearly half of its sales from India, unlike most of its domestic rivals for whom the US market makes up the bulk of revenues.
Jun 17, 2015 at 17:56 | Source: PTI
The government, however, rejected proposal of drug firm Strides Arcolab to issue shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals and deferred three proposals from other firms.